A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
Latest Information Update: 19 Feb 2024
At a glance
- Drugs Tigatuzumab (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Pharmacokinetics
Most Recent Events
- 21 Oct 2010 New trial record